Exact Sciences, Gastro Health & more — 5 GI company key notes

Written by Rachel Popa | August 15, 2018 | Print  |

Here are five updates on GI companies from the past week:

Motus GI named Jeff Hutchison vice president of U.S. sales and commercial operations.

Motus GI released its second quarter 2018 financial results, posting a $4.2 million net loss, or $0.27 per diluted share.

Exact Sciences, the manufacturer of Cologuard, and the Green Bay Packers launched "Crossing the 50," a new campaign to raise money for the Vince Lombardi Cancer Foundation.

Miami-based Gastro Health made a series of leadership appointments as the practice continues to expand.

The FDA awarded Array Biopharma's mutant metastatic colorectal cancer treatment the breakthrough therapy designation.

More articles on gastroenterology:
'U.S. News and World Report' names the top 10 hospitals for GI
Motion filed to limit media contact for gastroenterologist accused of sexual misconduct
ASGE recognizes Chicago gastroenterologist for quality: 4 insights

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.